SEC Comment Letter 0000000000-23-010767 to INNO HOLDINGS INC. (INHD)
INNO HOLDINGS INC.
Date: Sept. 29, 2023 · CIK: 0001961847 · Accession: 0000000000-23-010767
AI Filing Summary & Sentiment
File numbers found in text: 333-273429
Show Raw Text
United States securities and exchange commission logo
September 29, 2023
Dekui Liu
Chief Executive Officer
INNO HOLDINGS INC.
2465 Farm Market 359 South
Brookshire, TX 77423
Re:INNO HOLDINGS INC.
Amendment No. 2 to Registration Statement on Form S-1
Filed September 14, 2023
File No. 333-273429
Dear Dekui Liu:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Amendment No. 2 to Registration Statement on Form S-1 filed September 14, 2023
Prospectus Summary, page 4
1.Your net loss for the nine months ended June 30, 2022 disclosed on page 4 does not
appear consistent with the amount disclosed in the statement of operations on page F-4.
Please advise or revise.
Capitalization, page 39
2.Please address the following items related to your capitalization disclosures:
•Your pro forma column appears to represent adjustments made to arrive at the pro
forma as adjusted amounts. If true, revise the column headers as well as your
description of these columns in the introductory paragraph;
•Tell us and disclose why deferred offering costs are included in your capitalization;
FirstName LastNameDekui Liu
Comapany NameINNO HOLDINGS INC.
September 29, 2023 Page 2
FirstName LastName
Dekui Liu
INNO HOLDINGS INC.
September 29, 2023
Page 2
and
•Disclose in the footnote the impact on your capitalization if your underwriters
exercise their over-allotment option in full.
Dilution, page 40
3.Please revise to calculate net tangible book value excluding any intangible assets such as
deferred offering costs.
Results of Operation
Bad debt expense, page 44
4.Please provide additional information regarding the significant increase in bad debt
expense during the nine month period ended June 30, 2023, including the contractual and
customary payment terms of your accounts receivables. Consider providing an aging of
your accounts receivable as of the latest balance sheet date in tabular form and showing
the allowance for credit losses related to each age group of receivables.
Note 4 - Accounts Receivable, Net, page F-15
5.The June 30, 2023 accounts receivable, net amount disclosed on page F-15 does not
appear consistent with the amount presented in the balance sheet on page F-2. Please
advise or revise.
Note 15 - Subsequent Events, page F-20
6.You disclose that you effected a reverse stock split at a split ratio of 1-for-2 on July 24,
2023. Please tell us how your financial statements retroactively give effect to the reverse
stock split for all periods presented. Refer to ASC 505-10-S99 and SAB Topic 4C.
You may contact SiSi Cheng, Staff Accountant, at 202-551-5004 or Kevin Woody,
Accounting Branch Chief, at 202-551-3629 if you have questions regarding comments on the
financial statements and related matters. Please contact Thomas Jones, Staff Attorney, at 202-
551-3602 or Jay Ingram, Legal Branch Chief, at 202-551-3397 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Michael J. Blankenship